Quick Answer
Pomegranate Sleep Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Conclusion In conclusion, a novel PB showed promise for attenuating muscle pain and perceived exhaustion, and improving sleep quality, in the days after muscle damaging exercise.
Key Takeaways
- 01Conclusion In conclusion, a novel PB showed promise for attenuating muscle pain and perceived exhaustion, and improving sleep quality, in the days after muscle damaging exercise. [Thorley J (2026)]
- 02Background and objectives This study examined the effects of a novel phytochemical supplement blend on markers of exercise-induced muscle damage. [Thorley J (2026)]
- 03Methods In a randomised, parallel group design, 24 healthy participants (14 males) consumed 300 mg of a phytochemical blend (calcium fructoborate, turmeric and pomegranate; PB) or inert placebo for 9 days (n = 12 per condition). [Thorley J (2026)]
- 04—Which populations and contexts (training status, sex and age, dietary pattern and energy availability, heat or hypoxia, and congested competition schedules) shift the balance from benefit to risk? [Mănescu Dan Cristian (2026)]
The current Migaku evidence database contains 2 reusable source documents for Pomegranate Sleep Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- Conclusion In conclusion, a novel PB showed promise for attenuating muscle pain and perceived exhaustion, and improving sleep quality, in the days after muscle damaging exercise. [Thorley J (2026); evidence level 2]
- Background and objectives This study examined the effects of a novel phytochemical supplement blend on markers of exercise-induced muscle damage. [Thorley J (2026); evidence level 2]
- Methods In a randomised, parallel group design, 24 healthy participants (14 males) consumed 300 mg of a phytochemical blend (calcium fructoborate, turmeric and pomegranate; PB) or inert placebo for 9 days (n = 12 per condition). [Thorley J (2026); evidence level 2]
- —Which populations and contexts (training status, sex and age, dietary pattern and energy availability, heat or hypoxia, and congested competition schedules) shift the balance from benefit to risk? [Mănescu Dan Cristian (2026); evidence level 3]
- This review addresses that problem for athletes and practitioners seeking evidence-based guidance. [Mănescu Dan Cristian (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources